Article Text
Statistics from Altmetric.com
In 2011, a case was reported in which a patient with multiple sclerosis (MS) and HIV was treated with antiretroviral therapy (ART)—he did not experience MS-related deficits for over a decade.1 This prompted researchers in Denmark (Nexø et al) to examine the association between MS and HIV using population-based databases. Although they found a reduced incidence of MS in HIV-positive individuals compared with the general population, their study did not achieve a conventional level of statistical significance.2 I was recently asked to review the Gold et al study,3 which has answered the Danish researchers’ call for a larger study to investigate whether HIV, or its treatment, has a protective effect on the development of MS.
Similar to the original Danish study, Gold et al used administrative health databases to fulfil their research objectives; in …
Footnotes
-
Funding MLVDK is supported by a Canadian Institutes of Health Research (CIHR) Doctoral Award – Doctoral Foreign Study Award (October 2012), offered in partnership with the CIHR Strategy for Patient-Oriented Research and the CIHR HIV/AIDS Research Initiative.
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.